Canada markets close in 3 hours 11 minutes

Forte Biosciences, Inc. (FBRX)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
0.7300+0.0190 (+2.67%)
As of 12:22PM EDT. Market open.
Currency in USD

Valuation Measures4

Market Cap (intraday) 26.39M
Enterprise Value -10.74M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)N/A
Price/Book (mrq)0.75
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA 0.33

Trading Information

Stock Price History

Beta (5Y Monthly) 1.65
52-Week Change 3-32.24%
S&P500 52-Week Change 324.19%
52 Week High 31.1500
52 Week Low 30.3800
50-Day Moving Average 30.7061
200-Day Moving Average 30.7038

Share Statistics

Avg Vol (3 month) 334.45k
Avg Vol (10 day) 319.8k
Shares Outstanding 536.39M
Implied Shares Outstanding 636.39M
Float 822.01M
% Held by Insiders 110.92%
% Held by Institutions 156.16%
Shares Short (Apr 15, 2024) 433.02k
Short Ratio (Apr 15, 2024) 41.36
Short % of Float (Apr 15, 2024) 40.10%
Short % of Shares Outstanding (Apr 15, 2024) 40.09%
Shares Short (prior month Mar 15, 2024) 442.18k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3Jun 16, 2020
Ex-Dividend Date 4N/A
Last Split Factor 21:15
Last Split Date 3Jun 16, 2020

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-50.15%
Return on Equity (ttm)-84.92%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -32.48M
Net Income Avi to Common (ttm)-31.48M
Diluted EPS (ttm)-1.0000
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)37.12M
Total Cash Per Share (mrq)1.02
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)10.45
Book Value Per Share (mrq)0.97

Cash Flow Statement

Operating Cash Flow (ttm)-28.71M
Levered Free Cash Flow (ttm)-17.4M